|
 
 |
| LETTER TO EDITOR |
|
| Year : 2020 | Volume
: 11
| Issue : 1 | Page : 30 |
|
Positive screening for Wuhan novel coronavirus infection at international airport: What's the final diagnosis for positive cases
Won Sriwijitalai1, Viroj Wiwanitkit2
1 RVT Medical Center, Bangkok, Thailand
2 Department of Tropical Medicine, Hainan Medical University, Haikou, China; Department of Community Medicine, Dr DY Patil University, Pune, Maharashtra, India
| Date of Submission | 30-Jan-2020 |
| Date of Acceptance | 30-Jan-2020 |
| Date of Web Publication | 21-Feb-2020 |
Correspondence Address:
Won Sriwijitalai
RVT Medical Center, Bangkok
Thailand
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijpvm.IJPVM_42_20
How to cite this article:
Sriwijitalai W, Wiwanitkit V. Positive screening for Wuhan novel coronavirus infection at international airport: What's the final diagnosis for positive cases. Int J Prev Med 2020;11:30 |
How to cite this URL:
Sriwijitalai W, Wiwanitkit V. Positive screening for Wuhan novel coronavirus infection at international airport: What's the final diagnosis for positive cases. Int J Prev Med [serial online] 2020 [cited 2023 Oct 4];11:30. Available from: https://www.ijpvmjournal.net/text.asp?2020/11/1/30/279000 |
Dear Editor,
Active screening at the international airport is an important method in international infectious control. The main aim is for the prevention of imported new emerging infectious diseases. Recently, there was a newly emerging infectious disease, Wuhan novel coronavirus infection, from China that becomes the new global public health concern.[1] The countries with international flight connections with China implemented active screening at the international airport as a tool for infection control. Thailand is a country in Indochina that has 58 international flights connecting with Wuhan, China. Since the first outbreak of the disease in December 2019, the active screening at the airport (by body temperature scanning and clinical history taking) has been done to identify possible infected cases. In the first month, the active screening identified some positive screening cases. Here, the authors retrospectively reappraised on the available data on the final diagnosis of screening positive cases. Of overall 12 cases with positive screening, the final diagnosis by molecular diagnostic tests in referencing laboratories could identify only one case with Wuhan novel coronavirus infection, which is the first case report of infection outside China.[2] The other 11 cases are infected with the influenza virus. There is a high sensitivity (100%) for screening for any infections but low sensitivity for screening for specific disease, Wuhan novel coronavirus infection (false positive rate = 91.67%). It can imply that active screening at the international airport can help screen for febrile illness but it is not specific for screening for a specific emerging infection.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | |  |
| 1. | Hsia W. Emerging new coronavirus infection in Wuhan, China: Situation in early 2020. Case Study Case Rep 2020;10:8-9.  |
| 2. | Yasri S, Wiwanitkit V. Editorial: Wuhan coronavirus outbreak and imported case. Adv Trop Med Pub Health Int 2019;9:1-2. |
| This article has been cited by | | 1 |
COVID-19 pandemic mistakes and monkeypox: Correspondence |
|
| R. Mungmunpuntipantip, V. Wiwanitkit | | Pulmonology. 2022; | | [Pubmed] | [DOI] | | | 2 |
Imported COVID-19: The Challenges of Emigration Screening |
|
| Rujittika Mungmunpuntipantip,Viroj Wiwanitkit | | Disaster Medicine and Public Health Preparedness. 2021; : 1 | | [Pubmed] | [DOI] | | | 3 |
Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management |
|
| Baback Gharizadeh,Junqiu Yue,Mingxia Yu,Yue Liu,Meiying Zhou,Daru Lu,Jingwei Zhang | | IEEE Reviews in Biomedical Engineering. 2021; 14: 30 | | [Pubmed] | [DOI] | | | 4 |
International travel-related control measures to contain the COVID-19 pandemic: a rapid review |
|
| Jacob Burns,Ani Movsisyan,Jan M Stratil,Renke Lars Biallas,Michaela Coenen,Karl MF Emmert-Fees,Karin Geffert,Sabine Hoffmann,Olaf Horstick,Michael Laxy,Carmen Klinger,Suzie Kratzer,Tim Litwin,Susan Norris,Lisa M Pfadenhauer,Peter von Philipsborn,Kerstin Sell,Julia Stadelmaier,Ben Verboom,Stephan Voss,Katharina Wabnitz,Eva Rehfuess | | Cochrane Database of Systematic Reviews. 2021; | | [Pubmed] | [DOI] | | | 5 |
Universal screening for SARS-CoV-2 infection: a rapid review |
|
| Meera Viswanathan,Leila Kahwati,Beate Jahn,Kayla Giger,Andreea Iulia Dobrescu,Christine Hill,Irma Klerings,Jana Meixner,Emma Persad,Birgit Teufer,Gerald Gartlehner | | Cochrane Database of Systematic Reviews. 2020; | | [Pubmed] | [DOI] | | | 6 |
Travel-related control measures to contain the COVID-19 pandemic: a rapid review |
|
| Jacob Burns,Ani Movsisyan,Jan M Stratil,Michaela Coenen,Karl MF Emmert-Fees,Karin Geffert,Sabine Hoffmann,Olaf Horstick,Michael Laxy,Lisa M Pfadenhauer,Peter von Philipsborn,Kerstin Sell,Stephan Voss,Eva Rehfuess | | Cochrane Database of Systematic Reviews. 2020; | | [Pubmed] | [DOI] | | | 7 |
Cost–utility analysis for chest CT versus RT-PCR for COVID-19 detection |
|
| Won Sriwijitalai,Viroj Wiwanitkit | | International Journal of Preventive Medicine. 2020; 11(1): 67 | | [Pubmed] | [DOI] | | | 8 |
Coronavirus disease 2019 pandemic: Upscaling the preparedness and public health emergency response at the point of entry |
|
| SaurabhRamBihariLal Shrivastava,PrateekSaurabh Shrivastava | | Journal of Current Research in Scientific Medicine. 2020; 6(1): 63 | | [Pubmed] | [DOI] | |
|
 |
|
|
|
Search Pubmed for